Menopause is usually described as the end of periods, with a familiar list of symptoms: hot flashes, night sweats, sleep problems.

It’s also usually pictured as gradual. Hormones taper off over several years, and the body slowly adjusts.

A new study suggests both ideas may be incomplete.

Analyzing more than 300 million laboratory tests, researchers found that around the final menstrual period, dozens of measurements across the body change abruptly, like stepping off a ledge. Bone, liver, kidney, blood and cholesterol markers all shift.

Men of the same age show no such jump.

The study drew on more than 300 million lab tests from the US and Israel

The study, published in Nature Medicine on October 12, was led by researchers at the Weizmann Institute of Science in Israel, including systems biologist Uri Alon.

They used two very large sources of data:

  • NHANES, a long-running US national health survey with lab tests from 1999 to 2022.
  • Clalit, Israel’s largest health insurer, with records from about 1.3 million women aged 30 to 70 between 2004 and 2024.

Together, these covered more than 300 million lab results from over a million women, across 90 types of lab tests.

Women who were pregnant, or who took medications or had conditions known to affect a given test, were excluded from that test’s analysis.

A trick from astronomy sharpened the snapshots

There was a problem. Most of this data is a snapshot: each woman tested at one point, not followed through her whole transition.

And women reach menopause at different ages. If you simply average lab results by age, a sudden change at menopause gets smeared out, because at age 50 some women are well past menopause and others years away from it. A sharp step looks like a gentle slope.

Astronomers face a similar problem. Telescope images are blurred in predictable ways, and they use mathematical techniques to “un-blur” them.

The researchers applied the same idea, a technique called deconvolution. Because the distribution of menopause ages is well known, they could mathematically reverse the blur and reconstruct how lab values change relative to each woman’s final period, on average.

The method doesn’t tell any individual woman when her menopause happened. It reconstructs the average pattern across the population.

52 of 90 lab tests jumped at the final period

The result: a significant, step-like change at the final menstrual period in 52 of the 90 lab tests.

The biggest jumps were, as expected, in sex hormones such as estradiol and follicle-stimulating hormone.

But the changes went far beyond reproduction. They showed up in markers of:

  • bone turnover
  • liver function
  • kidney function
  • blood counts and blood chemistry
  • cholesterol and other lipids

Most shifts moved in the direction of higher disease risk.

There was one notable exception. Iron levels, hemoglobin and red blood cell measures improved, most likely because monthly blood loss stopped.

The pattern matched in both countries, and men showed no jump

The researchers checked whether the pattern held up across both datasets.

It did. The sizes of the jumps in the US and Israeli data were strongly correlated (r = 0.89, where 1.0 would mean a perfect match).

And when they applied the same analysis to men, they found no jumps. Men’s values changed gradually with age.

Hormone changes began more than a decade earlier

The reconstruction also suggested that hormonal changes start long before the final period.

Markers of ovarian reserve and reproductive hormones began changing more than a decade beforehand. Estradiol, for example, started falling about 12 years before the final menstrual period.

The authors say that’s roughly seven years earlier than previous long-term studies suggested.

The study also found that some health outcomes shifted around menopause. Osteoporosis rose faster in women than in men after this point, and heart attack and stroke rates increased. Depression and sleep problems showed a temporary rise in the year after the final period.

Women on hormone therapy showed smaller jumps

Women currently using menopausal hormone therapy showed smaller jumps in many lab tests, including bone, liver and kidney markers.

The tests that jumped most at menopause tended to be the ones most reduced in women on hormone therapy.

But this result needs caution. Women who choose hormone therapy may differ from those who don’t: they may be healthier, wealthier or have better access to care. The authors note this “healthy-user” bias and say randomized trials are needed.

The study does not show that hormone therapy prevents these changes, or that it improves long-term health outcomes.

Menopause reaches far beyond reproduction

The bigger idea is that menopause isn’t just a reproductive event.

Estrogen and related hormones act on tissues throughout the body, including bones, the liver, kidneys, blood vessels and the brain. When ovarian hormone production falls, the effects ripple outward.

This study suggests that ripple is sharper and broader than commonly assumed, which may help explain why risks of several chronic conditions change around midlife in women.

It also shows how averages can hide the shape of change. A cliff can look like a gentle hill when everyone reaches it at a different time.

What the study doesn’t show

This is a peer-reviewed study, but the abruptness is reconstructed statistically from snapshot data. Women were not followed individually through menopause.

The results depend on assumptions about the distribution of menopause ages. Menopause status was self-reported, and some procedures, such as hysterectomy, can make the final period hard to pin down.

The hormone therapy findings are observational and may reflect who chooses therapy.

And lab markers shifting toward higher risk does not mean every woman will develop disease.

Menopause is a body-wide turning point

For many women, menopause care focuses on symptoms. This research suggests it’s also a moment when bone, heart, liver, kidney and metabolic health may change at once.

A reasonable implication, though not one the study tested directly, is that midlife health checks could pay closer attention to these systems around menopause. Whether hormone therapy is right for any individual is a decision to make with a doctor.

Menopause may be less a slow fade than a single, body-wide turning point.